Those who have recovered from COVID-19 posses unique antibodies that could help others fight off the disease and Survivor Corps is a new website that connects these individuals with the scientific community.
Researchers are seeking to build a plasma bank reservoir from COVID-19 survivors and to design clinical trials to test the antibodies with those who have been exposed. The collection of these antibodies could begin immediately and research shows the best time to harvest antibodies from the blood is approximately 28 days after the onset of the virus.
The project stirred up notable media attention and was recently named as one of the top 20 innovative ideas to combat the pandemic by the Washington Post.
Pandemic Antibodies Blood Donations
Survivor Corps Connects COVID-19 Survivors to Blood Banks
Trend Themes
1. COVID-19 Antibody Donations - The rise in COVID-19 antibody donations creates an opportunity for startups to create new methods for collection, storage and distribution of these antibodies.
2. Antibody Treatments for COVID-19 - The development of clinical trials to test the efficacy of COVID-19 antibodies creates a potential market for pharmaceutical and biotech companies to design new antibody treatments.
3. Collaborative Platforms for Scientific Research - Survivor Corps’ success in connecting COVID-19 survivors to the scientific community highlights opportunities for entrepreneurs to create collaborative platforms connecting patients and the medical community.
Industry Implications
1. Biotechnology and Pharmaceuticals - Biotechnology and pharmaceutical companies can potentially leverage COVID-19 antibodies found in survivors to develop new treatments for COVID-19 patients.
2. Blood Banking and Transfusion Services - Blood banking and transfusion service providers can create new, specialized services geared towards collecting and distributing COVID-19 antibodies.
3. Healthcare Technology - Healthcare technology startups can create platforms that allow patients to easily donate and track their COVID-19 antibodies for use in scientific research and treatment development.